8[5]Forestier F, Belisle S, Rbitaille D,et al. Low-dose aprotinin is ineffective to treat excessive bleeding after cardiopulmonary bypass [J]. Ann Thorac Surg,2000,69(2):452
9Caus T, Albertini JN, Chi J, et al. Multiple valve replacement increases the risk of re operation for structural degeneration of bioprosthese[J] .J Heart Valve Dis, 1999,8(4): 376 ～ 383.
10Akins CW, Buckley MJ, Daggett WM, et al. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses[ J] .Ann Thorac Surg,1998,65(16): 1 545 ～ 1 551.
3ANTUNES M J, BARLOW J B. Management of tricuspid valve regurgitation[J]. Heart, 2007, 93(2): 271-276.
4ALSOUFI B, RAO V, BORGER M A, et al. Short-and long- term results of triple valve surgery in the modern era [ J ]. Ann Thorac Surg, 2006, 81(6): 2172-2178.
5FILSOUFI F, ANYANWU A C, SALZBERG S P, et al. Long- term outcomes of tircuspid valve replacement in the current era [J]. Ann Thorac Surg, 2005, 80(3) : 845-850.
7Kuwaki K,Morishita K,Tsukamoto M,et al.Tricuspid valve surgery for functional tricuspid valve regurgitationassociated with left-sided valvular disease[J].Eur J CardiothoracSurg,2001,20(3):577-582.
8Rizzoli G,Vendramin I,Nesseris G,et al.Biologicalor mechanical prostheses in tricuspid position A meta-analysis of intra-institutional results[J].Ann Thorac Surg,2004,77(5):1607-1614.
9Filsoufi F,Anyanwu AC,Salzberg SP,et al.Longtermoutcomes of tricuspid valve replacement in the current era[J].Ann Thorac Surg 2005,80(3):845-850.
